Market Value244,231,000
Total Holdings47
File Date2016-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TXMD / TherapeuticsMD, Inc. Call
ARCT / Arcturus Therapeutics Holdings Inc.
BIIB / Biogen Inc.
TNDM / Tandem Diabetes Care, Inc.
FLDM / Standard BioTools Inc
DVAX / Dynavax Technologies Corporation
ACOR / Acorda Therapeutics, Inc.
HTWR / Heartware International Inc.
CLVS / Clovis Oncology Inc Call
PACB / Pacific Biosciences of California, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
SRPT / Sarepta Therapeutics, Inc.
ZSAN / Zosano Pharma Corp
PTCT / PTC Therapeutics, Inc. Call
ZGNX / Zogenix Inc
RLYP / Relypsa, Inc.
ACHC / Acadia Healthcare Company, Inc.
CORI / Corium International, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
US3723091043 / GenMark Diagnostics, Inc
ONCE / Spark Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
OCRX / Ocera Therapeutics, Inc.
CYNA / Cynapsus Therapeutics Inc.
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
VCYT / Veracyte, Inc.
0PP / Portola Pharmaceuticals Inc
NVRO / Nevro Corp.
SGEN / Seagen Inc
TNXP / Tonix Pharmaceuticals Holding Corp.
EW / Edwards Lifesciences Corporation
NSTG / NanoString Technologies, Inc.
BLUE / bluebird bio, Inc.
SAGE / Sage Therapeutics, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ENTL / Entellus Medical, Inc.
INCY / Incyte Corporation
DSCI / Derma Sciences, Inc.
VTAE / Vitae Pharmaceuticals, Inc.
SBBP / Strongbridge Biopharma plc
NUVA / Nuvasive Inc
SPNC / Spectranetics Corp. (The)
BLCM / Bellicum Pharmaceuticals, Inc.
PCRX / Pacira BioSciences, Inc.
US33830X1046 / Five Prime Therapeutics Inc
ZLTQ / ZELTIQ Aesthetics, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
IART / Integra LifeSciences Holdings Corporation
RPTP / Raptor Pharmaceutical Corp.
NDRM / NeuroDerm Ltd.
BMYMP / Bristol-Myers Squibb Company - Preferred Security Call
AMGN / Amgen Inc.
ISRG / Intuitive Surgical, Inc.
US16706W1027 / Chiasma Inc
98235T107 / Wright Medical Group N.V.
MNKKQ / Mallinckrodt Plc
FATE / Fate Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc. Call
CELG / Celgene Corp.
GILD / Gilead Sciences, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Call
PRTA / Prothena Corporation plc
CBAY / CymaBay Therapeutics, Inc.
HCA / HCA Healthcare, Inc.
LRMR / Larimar Therapeutics, Inc.
CYH / Community Health Systems, Inc.
HRTX / Heron Therapeutics, Inc. Call
RGNX / REGENXBIO Inc.
ALNY / Alnylam Pharmaceuticals, Inc.